CannRX’s abstract has been accepted at the 2019 MJBizCon INT’L conference in Toronto, Canada. Dr. Bill Levine the Founder and Chief Scientific Officer of CannRX will deliver his presentation titled, “Development and Delivery: Science and New Technologies to Enhance Product Performance” on September 5 at 3:40 pm ET in Room 715.

The presentation is about the development of first-rate consistent cannabis products for medicinal and recreational use, from the extraction of ingredients to crafting of an optimized delivery system. Dr. Bill will also discuss the benefits of developing new technologies to facilitate the consistency of products.
MJBizCon INT’L begins on September 4th through 6th at the Metro Toronto Convention Center in Ontario. The event will feature 70 speakers and 150 exhibitors including the world’s leading cannabis experts.

About CannRX
CannRX, a subsidiary of Izun Pharmaceuticals, develops exclusive scientifically-based medical and recreational cannabis medical products. This company has developed proprietary formulations for sleep disorders and pain control. Other products the company is developing target Parkinson’s disease, oncology support, and sports industry recreation.


Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound